Roche Diagnostics Partnership
NAVIFY® Tumor Board 2.0 is the first product from our partnership with Roche Diagnostics. It enables a more comprehensive view of each patient so specialists may review all relevant files quickly and align on the best possible personalized treatment.
- NAVIFY® Tumor Board is a cloud-based workflow product that securely integrates and displays relevant aggregated data into a single, holistic patient dashboard for oncology care teams to review, align and decide on the optimal treatment for the patient. Incorporating medical image viewing and storage capabilities with other patient data, NAVIFY® Tumor Board enables tumor boards – multi-disciplinary teams who determine treatment plans for cancer patients – to have a more comprehensive view of each patient in one place.
NAVIFY® Guidelines App
Easily review the latest guidelines and record patient diagnostic and treatment paths within NAVIFY® Tumor Board.
- Up-to-date decision tools: Look up digitized clinical practice guidelines in NAVIFY Tumor Board
- Real-time visibility into guideline adherence : Reduce inefficiencies in payer reimbursement and hospital accreditation
- Guidelines based on patient information : Save time on complex cases without needing to recall recommendations from memory
- Treatment variance documentation : Specify alternate pathways, skip diagnostic or treatment steps, and record non-adherence rationale
Discover other GE Healthcare Oncology Solutions
*Only available in the US.
JB04377XX